Overall, all of these studies document a high incidence of FGFR-3 mutations in urothelial carcinoma, and they support that the LNVUC variant may exhibit an even higher incidence of FGFR-3 mutations especially in more pure histological type. This evidence concerns the gene FGFR3 and urothelial carcinoma.